Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 57% ± 22% | |
lung | 11 studies | 35% ± 15% | |
peripheral blood | 10 studies | 24% ± 9% | |
eye | 9 studies | 50% ± 24% | |
heart | 5 studies | 44% ± 16% | |
liver | 4 studies | 42% ± 21% | |
adipose | 4 studies | 45% ± 21% | |
pancreas | 3 studies | 41% ± 24% | |
bone marrow | 3 studies | 31% ± 11% | |
intestine | 3 studies | 21% ± 4% | |
kidney | 3 studies | 45% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5078.26 | 1439 / 1445 | 100% | 23.36 | 183 / 183 |
lung | 100% | 4795.19 | 577 / 578 | 97% | 14.71 | 1120 / 1155 |
brain | 99% | 3504.93 | 2620 / 2642 | 96% | 17.01 | 677 / 705 |
stomach | 100% | 4038.42 | 358 / 359 | 95% | 12.83 | 272 / 286 |
breast | 100% | 4859.58 | 457 / 459 | 94% | 19.24 | 1055 / 1118 |
intestine | 100% | 5529.83 | 966 / 966 | 94% | 9.88 | 494 / 527 |
pancreas | 99% | 2561.65 | 324 / 328 | 94% | 10.46 | 167 / 178 |
skin | 100% | 5583.44 | 1808 / 1809 | 90% | 13.05 | 425 / 472 |
bladder | 100% | 5097.57 | 21 / 21 | 88% | 9.53 | 442 / 504 |
thymus | 100% | 5324.45 | 652 / 653 | 88% | 12.57 | 531 / 605 |
prostate | 100% | 4489.67 | 245 / 245 | 87% | 12.81 | 438 / 502 |
ovary | 100% | 5917.84 | 180 / 180 | 87% | 8.76 | 372 / 430 |
kidney | 100% | 3005.57 | 89 / 89 | 85% | 10.56 | 768 / 901 |
uterus | 100% | 6005.23 | 170 / 170 | 83% | 9.44 | 380 / 459 |
adrenal gland | 100% | 4912.92 | 258 / 258 | 75% | 7.02 | 172 / 230 |
liver | 90% | 1424.85 | 204 / 226 | 51% | 3.50 | 209 / 406 |
adipose | 100% | 4744.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5583.70 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4001.05 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 4958.99 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 91% | 2770.15 | 786 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 10.55 | 36 / 45 |
peripheral blood | 77% | 3172.39 | 713 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 6.64 | 60 / 80 |
lymph node | 0% | 0 | 0 / 0 | 62% | 11.16 | 18 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071108 | Biological process | protein K48-linked deubiquitination |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0006508 | Biological process | proteolysis |
GO_0016579 | Biological process | protein deubiquitination |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP34 |
Protein name | Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) Ubiquitin specific peptidase 34 ubiquitinyl hydrolase 1 (EC 3.4.19.12) Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34) |
Synonyms | KIAA0729 KIAA0570 |
Description | FUNCTION: Ubiquitin hydrolase that can remove conjugated ubiquitin from AXIN1 and AXIN2, thereby acting as a regulator of Wnt signaling pathway. Acts as an activator of the Wnt signaling pathway downstream of the beta-catenin destruction complex by deubiquitinating and stabilizing AXIN1 and AXIN2, leading to promote nuclear accumulation of AXIN1 and AXIN2 and positively regulate beta-catenin (CTNBB1)-mediated transcription. Recognizes and hydrolyzes the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins. . FUNCTION: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes. . |
Accessions | H7C150 ENST00000436269.1 Q70CQ2 ENST00000411912.5 H7BZ73 ENST00000398571.7 [Q70CQ2-1] ENST00000453734.1 H7C183 A0A0C4DG73 ENST00000453133.1 |